IHS Chemical Week

Regions :: Western Europe

Lanxess to revise strategy after sales and earnings plummet; 2014 target unrealistic

6:43 AM MDT | August 6, 2013 | Natasha Alperowicz

Lanxess today reported a 95% decline in second-quarter net income to €9 million ($11.9 million) on sales down 12% to €2.1 billion. Second-quarter Ebitda was down 45% at €198 million, corresponding to the company’s “middle of the guided range.” In its outlook Lanxess says 2013 Ebitda pre-exceptionals is likely to be €700 million-800 million, compared with the May guidance of “less than €1 billion”. The company says that the earlier reported 2014 Ebitda pre-exceptionals target for 2014 of €1.4 billion is...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa